IP Library Granted Patent US 8,772,509
Granted Patent B2
US 8,772,509 · App. 13/702,800 · Granted Jul 8, 2014

Indole compounds as positive allosteric modulators of the muscarinic receptor

Inventors: Craig W. Lindsley (Brentwood, TN); P. Jeffrey Conn (Brentwood, TN); Michael R. Wood (Brentwood, TN); James C. Tarr (Nashville, TN); Thomas M. Bridges (Nashville, TN)
Assignee: Vanderbilt University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,772,509
App. No.
13/702,800
Granted
Jul 8, 2014
Kind
B2
Abstract

In one aspect, the invention relates to indole compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claims (32)

1. A compound represented by a formula:

wherein each R 1a -R 1d is independently selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; provided that at least one of R 1a or R 1c is F;

wherein n is 0, 1, or 2;

wherein R 2 is selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;

wherein R 3 comprises two substituents independently selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;

wherein R 4 is selected from hydrogen, a hydrolysable residue, and optionally substituted alkyl;

wherein A 1 is selected from optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; and

wherein A 2 is selected from optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl.

2. The compound of claim 1 , wherein each of R 1a and R 1c is F.

3. The compound of claim 1 , wherein each of R 1b and R 1d is hydrogen.

4. The compound of claim 1 , wherein R 2 is hydrogen.

5. The compound of claim 1 , wherein n is 2.

6. The compound of claim 1 , wherein A 1 is selected from optionally substituted pyridine, optionally substituted pyrimidine, optionally substituted furan, optionally substituted thiophene, optionally substituted pyrrole, optionally substituted isoxazole, optionally substituted isothiazole, optionally substituted pyrazole, optionally substituted oxazole, optionally substituted thiazole, and optionally substituted imidazole.

7. The compound of claim 1 , wherein A 1 is optionally substituted oxazole.

8. The compound of claim 1 , wherein A 2 is selected from optionally substituted aryl and optionally substituted heteroaryl.

9. The compound of claim 1 , represented by a formula:

wherein R 5a , R 5c , and R 5e are independently selected from H, Cl, Br, F, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkoxy, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; and

wherein R 5b and R 5d are independently selected from H, Cl, Br, azido, amino, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkoxy, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; provided that at least one of R 5b and R 5d is not hydrogen.

10. The compound of claim 9 , wherein each of R 1a and R 1c is F.

11. The compound of claim 9 , wherein each of R 1b and R 1d is hydrogen.

12. A compound represented by a formula:

wherein each R 1a -R 1d is independently selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;

wherein n is 1 or 2;

wherein R 2 is selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;

wherein R 3 comprises two substituents independently selected from hydrogen, halogen, hydroxyl, thiol, sulfo, nitro, cyano, alkoxyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;

wherein R 4 is selected from hydrogen, a hydrolysable residue, and optionally substituted alkyl;

wherein A 1 is selected from pyridinyl, pyridinylmethyl, pyridazinyl, pyrimidinyl, 5-methylisoxazol-3-yl, benzoxazolyl, benzoisoxazolyl, oxetanyl, and thiazolyl, and A 1 is substituted with 0-2 groups selected from halogen, cyano, C1-C4 alkyl, C1-C4 alkoxyl, and C1-C4 haloalkyl;

wherein each R 5a -R 5e is independently selected from hydrogen, fluoro, chloro, bromo, iodo, azido, amino, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkoxy, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; provided that at least one of R 5a -R 5e is selected from optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl; or at least two of R 5a -R 5e are independently selected from fluoro, chloro, bromo, iodo, azido, amino, alkyl, and alkoxy.

13. The compound of claim 12 , wherein n is 2.

14. The compound of claim 12 , wherein at least one of R 5a -R 5e is selected from optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl.

15. The compound of claim 12 , wherein each R 1a -R 1d is hydrogen.

16. The compound of claim 12 , wherein at least one of R 1a or R 1c is F.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 1, 2016
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040483/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2014
From: LINDSLEY, CRAIG W.; CONN, P. JEFFREY; WOOD, MICHAEL R.; TARR, JAMES C.; BRIDGES, THOMAS M.
To: VANDERBILT UNIVERSITY
Reel/Frame 033149/0443 →
Continuity (2)
Provisional Application 61356741 · Jun 21, 2010
Related Publication 20130210773A1 · Aug 15, 2013